Psychedelic therapy – how much psychotherapy is part of it? | Felix Betzler & Michael Koslowski

Dr. med. Felix Betzler | Clinic for psychiatry and psychotherapy, Charité – University Medicine Berlin; Specialist
https://insight-conference.eu/speaker/felix-betzler/

Dr. med. Michael Koslowski | Clinic for psychiatry and psychotherapy, Charité – University Medicine Berlin; Specialist
https://insight-conference.eu/speaker/michael-koslowski/

--------------------
We are a non-profit organisation - but you can support our work with a donation! With your tax-deductible donation we can achieve our goals and visions. Every euro or dollar you donate will fund a project or researcher who is committed to safe and legal therapies, harm reduction and the development of the European health system. Please indicate "Betzler/Kosolwski Video" as the intended purpose.
Link: https://mind-foundation.org/donate
----------------------

Over the course of the long and interesting history of therapeutic use of psychedelics, various therapeutic settings and approaches emerged, spanning from shamanistic rituals to modern, manualized treatment sessions on a psychotherapeutic basis. Novel therapeutic settings in recent studies, which make the claim for integrating psychotherapeutic approaches, use elements of different psychotherapeutic directions in an eclectic way. Both aspects of modern behavioral and psychodynamic therapy found their way into the treatment sessions. Behavioral aspects include classical cognitive behavioral elements like motivational interviewing, as well as third wave therapies such as Acceptance and Commitment Therapy (ACT) or Mindfulness Based approaches. On the other hand, psychodynamic elements can be found in terms of working with dream-like states as a way to the subconscious, reducing psychological resistance, eliciting free association, insight and catharsis, and intensifying transference.
Furthermore, several common factors of psychotherapy can be found, such as high priority of a therapeutic alliance or substance-specific properties, e.g. increased suggestibility, or highly affective states like the psychedelic peak experience.
In this talk, Dr. Michael Koslowski, a therapist with a psychodynamic background and Dr. Felix Betzler, a behavioral therapist, will explore the range of therapeutic aspects of psychedelic therapy from two different perspectives.

--------------------

Felix Betzler is working as a psychiatrist and psychotherapist (behavioral therapy) at the Charité – university hospital Berlin. He obtained his medical education at the Charité and spent parts of his career as visiting research fellow at Harvard Medical School, where he also conducted his thesis in functional neuro-imaging. Next to his medical studies, he studied philosophy at Humboldt University.
Both clinically and scientifically, his focus lies on recreational drug use. He is the head of the work group “Recreational Drugs” at Charité, which is best known for their epidemiologic research about substance use and misuse in the Berlin Party scene and in Berlin’s Universities. Furthermore, his work group focuses on both harmful aspects of substance use when taken uncontrolled, and potential therapeutic effects of these substances in proper therapeutic settings (e.g. Psilocybin in the treatment of depression, MDMA-assisted therapy in PTSD). He is also in charge of the specialized consultation for ADHD in the Charité outpatient clinic.

Dr. med. Michael Koslowski is a medical doctor and did his PhD in functional neuroimaging on the dopaminergic reward system at the Charité Berlin. He completed his residency in psychiatry at the University hospitals in Berlin, Paris and Marseille. As a resident psychiatrist at the Department of Psychiatry and Psychotherapy of the Charité University Hospital in Berlin he works as a resident psychiatrist and psychotherapist in the fields of liaison psychiatry, emergency psychiatry, refugees with posttraumatic stress disorders, and psychodynamic therapy.
His research focus is on altered states of consciousness and novel treatment approaches for depression and other mental disorders, including classical psychedelics and mindfulness-based practices. He also investigates biological functions of dreaming, in collaboration with the International University of Psychoanalysis (IPU) Berlin, and is involved in research on machine learning-driven response prediction of therapies for depression at the Charité Campus Benjamin Franklin.

Видео Psychedelic therapy – how much psychotherapy is part of it? | Felix Betzler & Michael Koslowski канала MIND Foundation